Guoliang Zhang
Hefei, 230031, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Yiqi Jiedu Formula regulates immune microenvironment of liver cancer in mice by inhibiting overactivation of NF-κB signaling pathway
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: March 26, 2026
Study on the effect of Ursolic acid on liver cancer cells using z-vad-fmk and ROS inhibitors.
Journal: Cytotechnology
Published: January 16, 2026
Immunotherapy for virus-related hepatocellular carcinoma: recent progress and future directions.
Journal: Annals of medicine
Published: December 27, 2025
Transcriptomic profiling of HBV transgenic mouse livers reveals ZBP1-associated necroptotic signaling.
Journal: Scientific reports
Published: September 01, 2025
Mechanism of Hedyotis diffusa-Scutellaria barbata D. Don for treatment of primary liver cancer: analysis with network pharmacology, molecular docking and in vitro validation.
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: January 17, 2025
Identification of Key Drug Targets and Molecular Mechanisms of Curcumae Rhizoma Acting on HBV-Related HCC: Weighted Correlation Network and Network Pharmacological Analyses.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: February 08, 2022
The Protective Effects of a Modified Xiaohua Funing Decoction against Acute Liver Failure in Mice Induced by D-Gal and LPS.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: December 11, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026